Vijaya Diagnostic Centre Ltd Stock Price Today (NSE: VIJAYA)
Fundamental Score
Vijaya Diagnostic Centre Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vijaya Diagnostic Centre Ltd share price today is ₹861.40, down 3.08% on NSE/BSE as of 30 March 2026. Vijaya Diagnostic Centre Ltd (VIJAYA) is a Mid-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹10.27K (Cr). The 52-week high for VIJAYA share price is ₹1180.00 and the 52-week low is ₹813.15. At a P/E ratio of 67.39x, VIJAYA is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 19.00% and a debt-to-equity ratio of 0.42.
Vijaya Diagnostic Centre Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Vijaya Diagnostic Centre Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Vijaya Diagnostic Centre Share Price: A Conservative Value Investor's Perspective
Within the healthcare service provider landscape, a crucial element often overlooked is the pricing power afforded by strong brand recognition and established physician networks. This analysis examines the Vijaya Diagnostic Centre share price (₹965.200012) from the perspective of a conservative value investor, prioritizing capital safety above all else. The current Price-to-Earnings (PE) ratio stands at 67.39, suggesting the market anticipates significant future growth. A detailed fundamental analysis is necessary to assess if this valuation is justified.
One key indicator for a value investor is the Return on Capital Employed (ROCE). Vijaya Diagnostic Centre boasts a ROCE of 20.91%. This relatively high ROCE, if sustainable, can indicate a competitive advantage, or "moat." It demonstrates the company's ability to generate profit from its invested capital, potentially providing a buffer against economic downturns and competitors. A higher ROCE generally translates to more efficient capital allocation and stronger long-term shareholder value creation.
However, the relatively high PE ratio necessitates a cautious approach. When compared to sector peers such as
Suraksha Diagnostic Ltd, a deeper dive into management quality is essential. Assessing factors like corporate governance, capital allocation decisions, and long-term strategic vision becomes critical. While financial metrics provide a snapshot, understanding the leadership's aptitude for navigating the competitive landscape is paramount for long-term investment safety. Differences in management quality between Vijaya and peers like Suraksha Diagnostic can significantly impact future performance and justify differences in valuation.Further due diligence would involve a thorough examination of the company's debt levels, cash flow generation, and the sustainability of its growth rate. Analyzing the competitive intensity within its operating regions and the potential for disruption from new technologies or market entrants is also crucial. This assessment forms part of an 80-parameter fundamental audit, verified by Sweta Mishra, designed to identify potential red flags and assess the overall risk profile of Vijaya Diagnostic Centre Ltd. Remember, observational analysis is crucial; no investment recommendations are implied.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vijaya Diagnostic Centre Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VIJAYA across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (19.00%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (20.91%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (41.38%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (15.00% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (18.97% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (8.00x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹406.03 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (52.60%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 43.61%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 67.39x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Weak Earnings Growth (-36.26% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Vijaya Diagnostic Centre Ltd Financial Statements
Comprehensive financial data for Vijaya Diagnostic Centre Ltd including income statement, balance sheet and cash flow
About VIJAYA (Vijaya Diagnostic Centre Ltd)
Vijaya Diagnostic Centre Ltd is a prominent healthcare service provider renowned for its comprehensive and advanced diagnostic solutions. Boasting a wide spectrum of offerings, Vij...aya caters to diverse medical needs, from routine screenings to intricate investigations. They are equipped with cutting-edge technology and staffed by a team of highly skilled professionals, ensuring accurate and reliable results. Driven by a commitment to patient well-being, Vijaya Diagnostic Centre strives to be a trusted partner in healthcare, empowering individuals and medical practitioners with the insights needed for informed decisions and effective treatment strategies. Their commitment extends beyond just generating data; they aim to be a crucial link in the chain of patient care, providing clarity and support throughout the diagnostic journey. The core of Vijaya Diagnostic Centre's services lies in its extensive laboratory testing capabilities. This encompasses an array of disciplines, including pathology, microbiology, and advanced molecular diagnostics. Beyond traditional laboratory tests, Vijaya offers a wide array of imaging services, spanning from X-rays and ultrasounds to sophisticated CT scans, MRI scans, and PET/CT scans. Their dedication to technological advancement is evident in their provision of specialized services such as MRI-3T, ensuring high-resolution imaging for precise diagnoses. By integrating these diverse modalities, Vijaya Diagnostic Centre strives to provide a holistic diagnostic experience under one roof, simplifying the process for patients and clinicians alike. Their dedication to quality and innovation positions them as a leader in the diagnostic landscape. Further enhancing accessibility and convenience, Vijaya Diagnostic Centre extends its services beyond the confines of its physical locations. With comprehensive health checkup packages designed to suit varied needs, they enable proactive health management. Recognizing the importance of convenience in today's fast-paced world, Vijaya also offers home sample collection services, bringing diagnostic care directly to patients' doorsteps. This patient-centric approach underscores their dedication to providing seamless and accessible healthcare solutions. By combining advanced technology with a strong focus on patient comfort and convenience, Vijaya Diagnostic Centre is committed to revolutionizing the diagnostic experience and empowering individuals to take control of their health.
Company Details
Key Leadership
Corporate Events
Latest News
VIJAYA Share Price: Frequently Asked Questions
What is the current share price of Vijaya Diagnostic Centre Ltd (VIJAYA)?
As of 30 Mar 2026, 12:01 pm IST, Vijaya Diagnostic Centre Ltd share price is ₹861.40. The VIJAYA stock has a market capitalisation of ₹10.27K (Cr) on NSE/BSE.
Is VIJAYA share price Overvalued or Undervalued?
VIJAYA share price is currently trading at a P/E ratio of 67.39x, compared to the industry average of 39.28x. Based on this relative valuation, the Vijaya Diagnostic Centre Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of VIJAYA share price?
The 52-week high of VIJAYA share price is ₹1180.00 and the 52-week low is ₹813.15. These values are updated daily from NSE/BSE price data.
What factors affect the Vijaya Diagnostic Centre Ltd share price?
Key factors influencing VIJAYA share price include quarterly earnings growth (Sales Growth: 10.17%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Vijaya Diagnostic Centre Ltd a good stock for long-term investment?
Vijaya Diagnostic Centre Ltd shows a 5-year Profit Growth of 18.97% and an ROE of 19.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.42 before investing in VIJAYA shares.
How does Vijaya Diagnostic Centre Ltd compare with its industry peers?
Vijaya Diagnostic Centre Ltd competes with major peers in the Healthcare Service Provider. Investors should compare VIJAYA share price P/E of 67.39x and ROE of 19.00% against the industry averages to determine competitive standing.
What is the P/E ratio of VIJAYA and what does it mean?
VIJAYA share price has a P/E ratio of 67.39x compared to the industry average of 39.28x. Investors pay ₹67 for every ₹1 of annual earnings.
How is VIJAYA performing according to Bull Run's analysis?
VIJAYA has a Bull Run fundamental score of 53.7/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does VIJAYA belong to?
VIJAYA operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Vijaya Diagnostic Centre Ltd share price.
What is Return on Equity (ROE) and why is it important for VIJAYA?
VIJAYA has an ROE of 19.00%, which indicates excellent management efficiency. ROE measures how efficiently Vijaya Diagnostic Centre Ltd generates profits from shareholders capital.
How is VIJAYA debt-to-equity ratio and what does it indicate?
VIJAYA has a debt-to-equity ratio of 0.42, which indicates moderate leverage that should be monitored.
What is VIJAYA dividend yield and is it a good dividend stock?
VIJAYA offers a dividend yield of 0.20%, meaning you receive ₹0.20 annual dividend for every ₹100 invested in Vijaya Diagnostic Centre Ltd shares.
How has VIJAYA share price grown over the past 5 years?
VIJAYA has achieved 5-year growth rates of: Sales Growth 15.00%, Profit Growth 18.97%, and EPS Growth -36.26%.
What is the promoter holding in VIJAYA and why does it matter?
Promoters hold 52.60% of VIJAYA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Vijaya Diagnostic Centre Ltd.
What is VIJAYA market capitalisation category?
VIJAYA has a market capitalisation of ₹10272 crores, placing it in the Mid-cap category.
How volatile is VIJAYA stock?
VIJAYA has a beta of N/A. A beta > 1 suggests the Vijaya Diagnostic Centre Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is VIJAYA operating profit margin trend?
VIJAYA has a 5-year average Operating Profit Margin (OPM) of 41.38%, indicating the company's operational efficiency.
How is VIJAYA quarterly performance?
Recent quarterly performance shows Vijaya Diagnostic Centre Ltd YoY Sales Growth of 10.17% and YoY Profit Growth of 2.75%.
What is the institutional holding pattern in VIJAYA?
VIJAYA has FII holding of 18.27% and DII holding of 25.34%. Significant institutional holding often suggests professional confidence in the Vijaya Diagnostic Centre Ltd stock.